Reconstitution of drug transport by purified P-glycoprotein.
about
The remarkable transport mechanism of P-glycoprotein: a multidrug transporter.Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1Mode of binding of anti-P-glycoprotein antibody MRK-16 to its antigen. A crystallographic and molecular modeling studyRetinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt diseaseMolecular properties of bacterial multidrug transportersMutational analysis and properties of the msbA gene of Escherichia coli, coding for an essential ABC family transporterPuromycin selectively increases mdr1a expression in immortalized rat brain endothelial cell linesStructural and functional asymmetry of the nucleotide-binding domains of P-glycoprotein investigated by attenuated total reflection Fourier transform infrared spectroscopyHopanoids as functional analogues of cholesterol in bacterial membranesBasic residues R260 and K357 affect the conformational dynamics of the major facilitator superfamily multidrug transporter LmrPbeta-Amyloid efflux mediated by p-glycoprotein.Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site.Ligand-mediated tertiary structure changes of reconstituted P-glycoprotein. A tryptophan fluorescence quenching analysis.Overexpression of the cystic fibrosis transmembrane conductance regulator in NIH 3T3 cells lowers membrane potential and intracellular pH and confers a multidrug resistance phenotype.Structure and function of efflux pumps that confer resistance to drugsThe translocation mechanism of P-glycoprotein.The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research.Optical imaging of tumors with copper-labeled rhodamine derivatives by targeting mitochondria.Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells.Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein.P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer.Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein.Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities.Functional intracellular P-glycoprotein.Cost, effectiveness and environmental relevance of multidrug transporters in sea urchin embryos.Evaluation of (64)Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance.Molecular analysis of the multidrug transporter, P-glycoprotein.Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.Functional expression of mouse Mdr1 in an outer membrane permeability mutant of Escherichia coli.Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function.Advances in plant-based inhibitors of P-glycoprotein.Single-vesicle estimation of ATP-binding cassette transporters in microfluidic channels.Expression and characterization of DrrA and DrrB proteins of Streptomyces peucetius in Escherichia coli: DrrA is an ATP binding protein.Purification of the human apical conjugate export pump MRP2 reconstitution and functional characterization as substrate-stimulated ATPase.Cell-cycle-dependent turnover of P-glycoprotein in multidrug-resistant cells.Multidrug resistance in Lactococcus lactis: evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane.Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulationGenome-Scale Genetic Interactions and Cell Imaging Confirm Cytokinesis as Deleterious to Transient Topoisomerase II Deficiency in Saccharomyces cerevisiae.Physicochemical factors controlling the activity and energy coupling of an ionic strength-gated ATP-binding cassette (ABC) transporter.
P2860
Q24547974-2335B56B-B174-4811-AB22-1D0AA4B51A40Q26778957-1854D20E-AEEF-4B97-A1E9-9E281434C0B4Q27765326-2325301A-4B31-43A3-8F30-630316F3D4EDQ28138732-0CCC48E7-2790-4854-AF2B-D7C1CC645A69Q28139376-219AC8A1-FB2C-42C3-86F8-CB82B5E74D66Q28290031-460C189E-7C68-4027-8D8A-E351334D7F68Q28569441-58A4304D-79FB-4FCE-BBF6-197621236D6FQ28585772-60D5D277-586B-4728-BE94-5272346DA0CBQ28607147-E6FF50E6-9C84-4FCD-882E-3658F1E41146Q28728211-2ED774AA-6A4E-4F23-BA02-9A0F4457A2C5Q31962046-4B457510-EA2E-4D19-A4BA-6D9800B502C8Q33177727-91B7543C-6D20-4A7D-AAE9-9C561AD83A7AQ33864499-0B9D8840-8421-4921-815B-32E94952E417Q34047158-F9DF95E7-03DD-44FA-8876-A24EC52FFFF6Q35294152-D4A5C409-B8BC-4A70-98C1-65D4B3F4266CQ36354417-E6542BA9-B6F1-4719-81AB-02489360B8C4Q36365560-3138B905-8D8B-453B-8FA3-B5E838C0E460Q36383722-191F7772-9A35-4F69-BF58-4B970EEE9F13Q36435761-B0A0BF7F-DB20-4E61-B7BD-BDC4CB1DB5AFQ36619892-3238CA01-408F-40A6-BE0E-36C850894584Q36691249-8169A523-0B3E-4DF3-8876-09D76432B615Q36895019-6D4CA3E5-A18F-484D-91F6-43C850582790Q36895024-D9E23F62-4EF2-4135-B26C-6191FF7B9C20Q36895030-A39CAFC4-709A-4A9C-8567-E9BC3DF5519AQ36897086-973DD08D-A64A-47FB-888F-40681A740E2EQ37200589-A6348B83-EB27-4FF7-A881-20BFC514785FQ37260774-90C9DEE5-64E2-45A8-A3BA-59CE677B54DBQ37323494-4A090E0E-556B-47A0-8514-5F8046398802Q37382642-5126CCD3-912A-4A37-AF82-0B4033DD7BFFQ37565994-C70BCE0F-C84C-4476-B48C-D3D7E3300CD3Q37612789-12DE82B7-B8B3-4F9D-81A9-0A42858C3EC7Q38756967-3DC6A23C-EEA9-460E-84C4-D1CFA4B76B5AQ39426133-14314240-56CF-4E6B-8B9B-C1000F84AF5EQ39844143-C358D582-CD9A-4643-8A0D-5937A1823B8CQ40797207-F2FF78EC-CA60-4E97-B457-31E4E709BB27Q40877779-8E7768B3-57A1-47AE-8CF5-D25495248298Q41076661-9215C129-555C-4ED9-B551-8CB990CA3D23Q41907216-A748AB56-E5BB-4587-811D-70F133B539CAQ42373237-C8F2F1B6-5FB8-4887-A67F-F6308EA9F0DDQ42666651-7ECC2E9D-E131-4211-BFA5-09F961311F89
P2860
Reconstitution of drug transport by purified P-glycoprotein.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Reconstitution of drug transport by purified P-glycoprotein.
@ast
Reconstitution of drug transport by purified P-glycoprotein.
@en
type
label
Reconstitution of drug transport by purified P-glycoprotein.
@ast
Reconstitution of drug transport by purified P-glycoprotein.
@en
prefLabel
Reconstitution of drug transport by purified P-glycoprotein.
@ast
Reconstitution of drug transport by purified P-glycoprotein.
@en
P2860
P356
P1476
Reconstitution of drug transport by purified P-glycoprotein.
@en
P2093
P2860
P304
16167-16175
P356
10.1074/JBC.270.27.16167
P407
P577
1995-07-01T00:00:00Z